Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Trends Parasitol. 2016 Jun 1;32(10):798–807. doi: 10.1016/j.pt.2016.05.004

Eosinophils in helminth infection: defenders and dupes

Lu Huang 1,2, Judith A Appleton 1,2
PMCID: PMC5048491  NIHMSID: NIHMS792164  PMID: 27262918

Abstract

Eosinophilia is a central feature of the host response to helminth infection. Larval stages of parasitic worms are killed in vitro by eosinophils in the presence of specific antibodies or complement. These findings established host defense as the paradigm for eosinophil function. Recently, studies in eosinophil-ablated mouse strains have revealed an expanded repertoire of immunoregulatory functions for this cell. Other reports document crucial roles for eosinophils in tissue homeostasis and metabolism, processes that are central to the establishment and maintenance of parasitic worms in their hosts. In this review, we summarize current understanding of the significance of eosinophils at the host-parasite interface, highlighting their distinct functions during primary and secondary exposure.

Keywords: eosinophil, helminth, type 2 immunity

Eosinophils in the host-parasite interface

Helminths are highly complex, macroscopic animals that incorporate nervous, excretory, gastrointestinal, muscular, and reproductive systems. Despite their complexity, parasitic helminths depend upon a host to compensate for lost functions that enable a free-living lifestyle. The host provides a supportive physical and metabolic environment for growth, reproduction, and maturation, often for months or years, even though the size and motility of worms is such that tissue trauma is a common feature of infection.

In parasitic infections of animals, a potent Th2-driven immune response occurs that is coincident with the metabolic and physical interaction between host and worm. Effector mechanisms that clear worms from the body vary depending upon the habitat and niche of the parasite. Best understood in the intestine, in some instances goblet cells are critical [1], in others mast cells [2] or antibodies [35] play important roles in host defense. Immune mediators may cause displacement [3, 4], deprive the worm of energy or nutrients [1], or disrupt the habitat [6]. By a similarly varied array of mechanisms, worms evade or co-opt the immune response in order to complete their life cycles and be transmitted to the next host [7].

Representing less than 5% of blood leukocytes in healthy animals, tissue and blood eosinophils increase dramatically during worm infection [8].The type 2 cytokine IL-5 plays a central role in inducing activation and recruitment of eosinophils to sites of infection, while eotaxin also promotes eosinophilia [9, 10]. It has been widely accepted that eosinophils are defensive effector cells downstream of Th2 activation. This paradigm is supported by early studies that showed the capacity of eosinophils to kill helminth larvae in vitro [11, 12]. The availability of eosinophil-ablated mouse models has enabled experimentation to test functions of eosinophils in vivo. Data from several mouse models show that eosinophils are often dispensable, in some instances protect the host, and, surprisingly, in other instances protect the worm. The properties and functions of eosinophils have been reviewed in recent years [9, 13, 14]. In this review we will summarize recent progress in our understanding of the role of eosinophils in worm infection, emphasizing differences in function during primary and secondary exposure.

Mouse models that disrupt eosinophil function

Early studies of eosinophil function in mouse models of worm infection relied upon antibody-mediated depletion of eosinophils or IL-5 [15, 16]. Subsequently, mouse strains were engineered to be deficient in IL-5[10], in eotaxins [1719] or their receptor CCR3 [1720], or to overexpress IL-5 (IL-5Tg) [21]. Although expansion and recruitment of eosinophils are profoundly altered in these strains, the lineage is not ablated and this complicates the interpretation of negative results. Two eosinophil-ablation models, PHIL and ΔdblGATA [22, 23], enabled definitive experiments that confirmed some prior findings but also revealed previously unknown properties of eosinophils (Table 1). The two strains were engineered using different approaches. In PHIL mice, diphtheria toxin (DT) A chain was inserted downstream of the eosinophil peroxidase promoter, resulting in eosinophil apoptosis [22]. In contrast, ΔdblGATA mice bear a deletion of the high-affinity double GATA site in the GATA1 promoter that blocks the development of eosinophil lineage [23]. In addition, mice bearing dual deficiencies in the eosinophil secretory granule proteins MBP-1 [24] and EPX [25] were shown to manifest a specific and near complete loss of peripheral and tissue eosinophils [26]. This model offers an additional resource for testing eosinophil contributions to disease.

Table 1.

Documented influence of eosinophils on helminth infections in eosinophil-ablated PHIL or ΔdblGATA mice.

Helminth Primary Secondary References
Nippostrongylus
brasiliensis
- increased parasite egg
  production in intestinal
  phrase
- more larvae in the lung.
- impaired worm expulsion
  when CD4+ T cells were
  depleted
[43,90]
Heligmosomoides
polygyrus
-impaired worm expulsion - more worms trapped in
  the intestinal wall of mice
  immunized with
  excretory/secretory
  products
[44]
Trichinella spiralis - impaired growth of
  muscle larvae
- decreased burden of
  muscle larvae
- increased number of
  migratory newborn larvae
- increased muscle larvae
  burden
[45, 65,
76]
Brugia malayi - increased number of
  microfilarae
no impact [70]
Litomosoides
sigmodontis
- impaired development of
  filariae
unknown [89]
Trichuris muris no impact unknown [64]
Strongyloides
stercoralis
no impact no impact [62]
Schistosoma
mansoni
no impact unknown [63]

Adoptive transfer of eosinophils to eosinophil-ablated mice is an experimental design that considerably expands the utility of the model. Applied widely and creatively in recent years, transfer of eosinophils isolated from IL-5Tg mice into eosinophil-ablated or other genetically deficient recipients allows for testing of the significance and temporal requirements for eosinophil-derived factors in vivo [27]. The method can be elaborated upon, for example, by crossing IL-5Tg mice with major histocompatibility complex II deficient (MHCII−/−) mice to test the significance of antigen presentation by eosinophils in immunity [28]. Alternatively, bone marrow-derived eosinophils can be propagated in vitro for adoptive transfer experiments [29]. Although the number of cells produced by this method is limited, it provides a more rapid way to generate eosinophils with targeted genetic deficiencies.

A disadvantage of ablation models is that they do not enable contextual or temporal evaluation of eosinophil function in an otherwise eosinophil-replete animal. This challenge was addressed using knock-in strategies that inserted the gene for human diphtheria toxin receptor into the EPX locus [30, 31]. Depletion of eosinophils is induced by injection of the toxin. In the mouse model of asthma, inducible PHIL (iPHIL) mice were used to show that eosinophils were dispensable for sensitization to ovalbumin (OVA), although they were critical to the manifestation of disease following antigen challenge [30]. Although the approach has value for time-limited depletion of eosinophils, complete or sustained depletion is not readily achieved [30].

Eosinophils display a variety of receptors and produce an array of chemokines and cytokines that are known to be key regulators in different physiological and pathological processes [9, 32]. Their broad distribution across immune and other cell types makes it difficult to determine whether the eosinophil is the critical source of a particular mediator in the mechanism under investigation. A mouse model that addresses this need is one in which a gene knock-out is targeted specifically to eosinophils using Cre recombination [33].

As with any experimental approach, caution must be applied in interpreting results from available mouse models, as different gene targeting strategies, depletion methods and transfer designs may create artifacts. For example, ΔdblGATA mice display impaired generation and function of basophils [34], which should be taken into account when interpreting results. The growing collection of mouse strains available for eosinophil manipulation provides an array of tools and approaches that reduce this risk and significantly advance study of eosinophil function in vivo. A comprehensive summary of mouse strains for studying functions of eosinophil can be found in a recent review by Jacobsen et al [35]. Fortunately, the value of new mouse strains is combined with a generosity of spirit shown by their inventors in a way that has allowed the field to advance rapidly.

Secondary infection: confirming the dogma in vivo

Early in the study of parasitic disease, histological examination revealed that large numbers of eosinophils infiltrated sites of worm infection [36]. In the 1970s, eosinophils were shown to be capable of killing helminth larvae in vitro when combined with specific antibodies or complement [12, 37, 38], a form of antibody-dependent cellular cytotoxicity (ADCC), a process where immune effector cells kill target cells coated by specific antibodies. These findings engendered a dogma that the role of eosinophils is to protect the host against parasitic worms [11, 12, 39]. Indeed, helminth infection in mice induces a robust and diverse antibody response [40] and passive immunization with specific antibodies protects against some worm infections [3, 4, 41, 42].

Eosinophil-ablated mice have allowed testing of their effector function in secondary infection. In secondary subcutaneous larval infection with Nippostrongylus brasiliensis, increased numbers of larvae migrate to the lungs in IL-5−/− and ΔdblGATA mice [43]. Similarly, migration of Trichinella spiralis newborn larvae is increased in ablated versus WT mice and muscle larvae burdens are increased in ΔdblGATA mice upon secondary infection [45]. Earlier reports showed that eosinophils attach to newborn T. spiralis via specific antibodies, degranulating and killing the larva. Protection by eosinophils and antibodies has been documented in vivo by transferring sera or immunoglobulin from infected mice together with eosinophils to naïve ΔdblGATA mice prior to infection [45]. Although both EPX and MBP are toxic for newborn Trichinella in vitro, mice deficient in EPX or MBP show similar resistance to reinfection that is comparable to wild type mice (WT) (Figure 1). Although it is possible that MBP and EPX are functionally redundant, testing double knockouts is not feasible because such mice do not generate eosinophils [26].

Figure 1. Model of eosinophil mediated influences on primary and secondary infection by Trichinella spiralis.

Figure 1

In primary infection, Trichinella induces a mixed Th1 and Th2 immune response associated with eosinophilia in skeletal muscle. By secreting IL-10, eosinophils promote the expansion of IL-10-producing myeloid dendritic cells (DCs), and enhance the production of IL-10 by CD4+CD25 T cells. In macrophages and neutrophils, the production of nitric oxide (NO) by interferon-γ (IFN-γ)-activated inducible nitric oxide synthase (iNOS) is suppressed by IL-10, thereby promoting survival of muscle larvae. Independent of the adaptive immune response, eosinophils and IL-4 promote larval growth by controlling activation of STAT1, a signaling molecule that is known to attenuate insulin sensitivity and impair glucose uptake. The identity of cell(s) responsible for STAT1-dependent gene expression is not known. In secondary infection, eosinophils cooperate with antibodies to interfere with migratory newborn larvae (NBL), preventing their colonization of skeletal muscle and completion of the life-cycle.

An alternative to ADCC is a mechanism in which antibodies impede the movement of larvae in tissue, enabling binding and further impedance by eosinophils. Recent reports show that specific antibodies are capable of cooperating with basophils or alternatively activated macrophages to impede the mobility of N. brasiliensis or Heligmosomoides larvae, respectively [46, 47]. Larvae are also immobilized by eosinophils that are activated to release extracellular traps comprised of DNA fibers and eosinophil granule proteins [48, 49]. These mechanisms merit further investigation.

Specific antibodies are clearly important to protection against secondary helminth infection [40, 5052]. Plasma cells in the bone marrow are the main source of circulating antibodies and prolonged survival of these cells is crucial to sustaining a state of immunity. A variety of cell types that provide contact-dependent and secreted survival signals to plasma cells populate niches within the bone marrow. These include mesenchymal stromal cells [53], megakaryocytes [54], dendritic cells (DCs) [55, 56], macrophages [57], basophils [58] and eosinophils [59]. Bone marrow eosinophils have recently been implicated as a critical cellular source of the plasma cell survival factors, APRIL and IL-6 [59]. Using adoptive transfer protocols in eosinophil-ablated recipient mice, it was shown that plasma cell survival is further enhanced when eosinophils are first activated with adjuvant [60], consistent with a role for eosinophils in bone marrow plasma cell survival during infection. Eosinophils are also capable of regulating peripheral B cell homeostasis and proliferation in mice [61]. Although eosinophils are dispensable for the parasite-specific IgM response during primary infection by Strongyloides stercoralis [62], they are required for production of specific IgG2c in Trichinella infection [45]. Taken together, the findings suggest that eosinophils may guarantee their protective effector function by sustaining the cellular source of antibodies that are capable of binding Fc receptors on innate effector cells.

Primary infection: Location matters

Recent findings reveal a marked disparity in eosinophil influence among worms that colonize intestinal versus extra-intestinal sites (summarized in Figure 2). In PHIL and ΔdblGATA mice undergoing primary infection with Schistosoma mansoni, there are no obvious defects in immune responses, worm burdens, or egg deposition [63]. Furthermore, egg-induced liver lesions, including granuloma formation and fibrosis, are not affected by eosinophil ablation [63]. Larvae survival and development of primary and secondary immune responses are normal in PHIL mice infected with S. stercoralis [62]. Similarly, eosinophils are dispensable for the development of intestinal Th2 responses to Trichuris muris and worm expulsion is normal in ΔdblGATA mice [64]. Immune responses induced by primary infection with N. brasiliensis, are only marginally affected in ΔdblGATA mice [43]. Infection of either PHIL or ΔdblGATA mice with T. spiralis showed that eosinophils are dispensable for intestinal immunity that clears adult worms during primary infection [65]. Mechanisms of immunity across several enteric infections vary considerably, relying upon different effector cells and cytokines, yet a common feature is that eosinophils are generally unnecessary for immunity that clears primary infection. A notable exception was reported in a recent study of Heligmosomoides polygyrus infection that revealed a protective role of eosinophils in clearing intestinal adult worms [44].

Figure 2. Life cycles of selected helminths.

Figure 2

Different phases of infection in the mammalian host are highlighted in red. Symbols indicate life stages impacted by eosinophils in primary (|) or secondary (#) infection.

Primary infection: eosinophils, immune regulation and IL-10

Eosinophils enter tissues during inflammation induced by helminth infection [66] or hypersensitivity [67], providing them opportunity to interact with other responding cells. As the diversity of receptors and soluble mediators produced by eosinophils has been revealed, their potential to regulate immunity and influence disease has been tested at several levels.

In both allergic and helminth disease, eosinophils demonstrate the characteristics of antigen presenting cells. Exposure to allergens and worm antigens in vitro induces upregulation of co-stimulatory molecules CD80, CD86 and CD40 [68, 69]. In mice infected intraperitoneally with the human filarial parasite Brugia malayi, eosinophils upregulate surface MHC II enabling cognate interaction with T cells [69]. During T. muris infection, eosinophils display an activated phenotype with increased expression of Siglec-F, MHC II, and CD80 [64]. Studies of S. stercoralis infection clearly demonstrate that mouse eosinophils are capable of presenting antigens and initiating antigen specific T cell responses in vitro and in vivo [28]. Furthermore, eosinophils accumulate in mesenteric lymph nodes (MLN), preferentially localizing in the medulla and T cell zone during T. muris infection. Although receptor expression and tissue distribution are consistent with antigen presentation, there is no compelling, direct evidence that antigen presentation by eosinophils impacts the course of worm infection.

Recruitment of T cells is influenced by eosinophils. For example, T cell migration to the lung during allergic asthma is dependent upon eosinophil-derived chemokines [71, 72]. In addition, granules released by eosinophils have profound effects on recruitment and activation of dendritic cells, which in turn promote the development of Th2 responses [71, 72]. More recently, eosinophils have been shown to contribute to suppression of goblet cell mucus production in the lung and the IgE response in infection by the filarial nematode, B. malayi, providing indirect evidence for eosinophil-derived mediators that support immune regulation [70]. Importantly, eosinophils are required for clearance of B. malayi microfilarae in primary infection [70].

A dramatic impact of eosinophil-mediated immune regulation is evident during muscle infection by T. spiralis. Among parasitic worms, Trichinella is unusual in two ways: it completes its life cycle within one animal host and growth and development of all life-stages occurs intracellularly. First-stage larvae are ingested and develop into adult worms in the intestinal epithelium, where they reproduce. Newborn larvae (NBL) migrate from the intestine to skeletal muscles, invade myotubes, grow rapidly, and establish chronic, intracellular infection. Eosinophilia is prominent during both intestinal and extra-intestinal phases of infection; however, eosinophils do not contribute to intestinal immunity that expels worms from the gut or that which limits their fecundity [65, 73], nor do they influence liver injury caused by NBL as they migrate from the intestine [74, 75]. These findings are consistent with those from other mouse models of intestinal helminth infection, described above.

In stark contrast, eosinophils have a profound effect on the growth and survival of intracellular larvae in skeletal muscle. In both ΔdblGATA and PHIL mice, larval burdens in skeletal muscle are significantly reduced [65, 76]. Unlike the results obtained in secondary infection, NBL arrive in skeletal muscles of eosinophil-ablated mice in numbers comparable to wild-type mice. Poor larval survival in primary infection correlates with reduced infiltration of infected muscle by Th2 cells, associated with increased local production of nitric oxide (NO) [76]. NO is toxic for growing larvae [76].

Among leukocytes that infiltrate infected muscle, IL-10 from CD4+CD25 T cells suppresses interferon-γ (IFN-γ) production and induction of inducible nitric oxide synthase (iNOS) in macrophages and neutrophils [77]. Importantly, larval burdens are reduced in IL-10 deficient mice [65, 77, 78] confirming a central role for IL-10 in promoting survival of intracellular larvae. In the absence of eosinophils, IL-10+CD4+ T cells are reduced, implicating eosinophils as drivers of the IL-10 response [76, 79]. Notably, MHCII expression on eosinophils is not required for the expansion of IL-10+CD4+ T cells, suggesting that antigen presentation is not important to the function of eosinophils during infection[79]. Transfer of IL-10 competent eosinophils to ablated mice, at the initiation of muscle infection, expands IL-10-producing myeloid DCs and CD4+ T cells which in turn inhibit the production of local NO and protect muscle larvae (Figure 1). Indeed, transfer of IL-10 competent DCs or CD4+ T cells compensates for eosinophil deficiency [79]. These findings are consistent with an earlier report that eosinophils were required for DC recruitment and accumulation in lung draining lymph nodes in the allergy model [27]. Unsolved questions include the mechanism of DC recruitment by eosinophils.

Primary infection: Eosinophils, worm growth, and IL-4

In addition to evading host defense, successful colonization of the host requires that the parasite secure nutrients that support its growth. This demand for energy often occurs concurrently with tissue injury. In recent years, important roles for eosinophils have been revealed in both metabolism and tissue regeneration, for example, eosinophils are critical to maintaining homeostasis in white adipose tissue (WAT) and orchestrating biogenesis of beige fat [8082]. IL-4, a critical cytokine for Th2 immunity, is a central mediator in each case [8084]. Worms are strong inducers of IL-4. Following the intraperitoneal injection of schistosome eggs, mouse eosinophils are recruited and produce IL-4 [85], demonstrating that eosinophils have potential to initiate or polarize Th2 immunity to worms. Results from 4get mice (IL-4-EGFP reporter mice) infected with N. brasiliensis further confirmed the capacity of eosinophils for rapid production of IL-4 [86].

Eosinophils have been linked to IL-4 driven regenerative responses to tissue injury [83, 84]. Following cardiotoxin injection into skeletal muscle, eosinophils are dominant among IL-4-secreting cells that infiltrate the site, and the regenerative response is severely compromised in ΔdblGATA mice. Fibro/adipogenic progenitor cells (FAPs) at the site of injection are induced to express IL-4Rα. IL-4 drives proliferation of FAPs, preventing their differentiation into adipocytes and supporting myogenic differentiation. Additional findings support the conclusion that FAPs promote muscle regeneration through their ability to phagocytose necrotic fibers [83]. In the liver, infiltrating eosinophils are responsible for promoting IL-4-dependent regenerative responses to injury caused by CCl4 [84]. Liver regeneration in this model is dependent, in part, on IL-4Rα expression on hepatocytes. These observations provide evidence that eosinophils and IL-4 contribute to tissue repair in two highly regenerative organs. In each instance, IL-4 binds to resident or recruited, non-immune cells.

In contrast with the findings in models of liver injury described above, experiments with parasitic worms provide evidence that responses to injury vary, depending on both the insult and the tissue. For example, liver injury is a prominent feature of the granulomatous response to S. mansoni, yet eosinophils do not influence the development of granulomas in the livers of infected mice [63]. Similarly, eosinophils do not play a role in protecting the liver against damage caused by migrating Trichinella larvae [74, 75]. In contrast, eosinophils are highly active in skeletal muscle invaded by Trichinella [65, 76, 87].

Following entry into skeletal muscle cells, NBL undergo a period of growth over the course of 20 days. Larvae grow poorly in muscles of eosinophil-ablated mice. This effect is distinct from NO mediated killing and occurs independently of an adaptive immune response [76, 79]. Host gene expression in skeletal muscle following NBL invasion reflects a regenerative response. Specifically, the presence of eosinophils suppresses local inflammation (e.g. a STAT1 signature) while also influencing nutrient homeostasis. Eosinophils are known to regulate glucose homeostasis [82]. In wild-type mice, nurse cells redistribute glucose transporter 4 (GLUT4) and phosphorylate Akt, correlating with glycogen storage by larvae that is known to occur. The data are consistent with a mechanism in which eosinophils promote larval growth by an IL-4 dependent mechanism that limits local interferon-driven responses that otherwise alter nutrient availability in infected muscle. (Figure 1).

Although IL-5 is a critical cytokine in regulating activity of eosinophils, Trichinella larval growth is not affected by IL-5 deficiency. This is an important observation in the context of glucose uptake, as recent reports showing that lineage negative, innate lymphoid type 2 cell (ILC2) produces large quantities of type 2 cytokines IL-5 and IL-13. Accumulation of eosinophils and alternatively activated macrophages (arginase-1 positive; AAMs) in mouse visceral adipose tissue (VAT) depends upon IL-5 and IL-13, respectively [82, 88]. ILC2s in VAT are the major source of these cytokines[88]. IL-4 dependent AAMs in VAT are associated with metabolic syndrome, type 2 diabetes, and insulin resistance. Eosinophils are the predominant source of local IL-4 in VAT [82]. The recruitment of IL-4-producing eosinophils to VAT by IL-5-producing ILC2s further promotes alternative activation of adipose resident macrophages, which are required for increasing systemic insulin sensitivity. This model may be relevant to infection with Litosomoides sigmodontis. L. sigmodontis larvae show impaired growth in the absence of either eosinophils or IL-5 [89]. In contrast, ILC2-dependence is not supported for Trichinella infected muscle. Larvae grow normally in either ILC2 or IL-5 deficient mice, suggesting that a distinct mechanism is at work in skeletal muscle [87].

Concluding remarks

Mouse models of eosinophil ablation and related research tools have enriched our understanding of eosinophil function in health and disease. Across several models of worm infection, the influence of eosinophils ranges from insignificant to pivotal. Dramatic differences in function are evident in primary versus secondary infection and also in intestinal versus non-intestinal infections. The dogma that eosinophils are defenders clearly applies in secondary infection, while in primary infection of extra-intestinal sites, eosinophils protect the parasite. By promoting delivery of essential host resources that support parasite growth and preventing a toxic immune response that causes larval destruction, eosinophils appear to be duped by worms. Further exploration of this developing story is an exciting prospect. Determining whether eosinophils and worms are similarly complicit in other animal species will be of particular interest, with important implications for managing and preventing infections in people and animals.

Outstanding questions.

How does the antibody-mediated effector function of eosinophils compromise larvae: adherence, impedance by extracellular traps, killing by toxic granules?

What accounts for the tissue-dependent variation in eosinophil function and influence on parasitic worm infection?

How are eosinophils called into skeletal muscle within hours of colonization by Trichinella larvae?

How does IL-4 support larval growth: by a direct effect on infected cells, by influencing cells adjacent to the nurse cell, by inhibiting STAT1 dependent responses that limit glucose availability to infected cells?

What is the relevance of findings in mouse models to diseases in humans and other animals?

Trends.

Parasitic worms exploit cells and cytokines of the innate immune system that are critical to metabolic homeostasis and responses to injury.

The influences of innate and adaptive immune mediators on parasitic infection vary among tissue/organ systems, e.g. IL-4 promotes expulsion of worms from the intestine, yet supports worm survival in extra-intestinal sites.

Eosinophils sometimes have a profound influence on helminth infection that is independent of eosinophilia and Th2 driven immunity.

Acknowledgments

This works was supported by National Institutes of Health grants AI081043 and AI097555 (JAA).

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Conflict of interest

The authors have no conflicts of interest.

References

  • 1.Herbert DR, et al. Intestinal epithelial cell secretion of RELM-beta protects against gastrointestinal worm infection. J Exp Med. 2009;206:2947–2957. doi: 10.1084/jem.20091268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ha TY, et al. Delayed expulsion of adult Trichinella spiralis by mast cell-deficient W/Wv mice. Infection and immunity. 1983;41:445–447. doi: 10.1128/iai.41.1.445-447.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Appleton JA, McGregor DD. Rapid expulsion of Trichinella spiralis in suckling rats. Science. 1984;226:70–72. doi: 10.1126/science.6474191. [DOI] [PubMed] [Google Scholar]
  • 4.Appleton JA, et al. Rapid expulsion of Trichinella spiralis in suckling rats: mediation by monoclonal antibodies. Immunology. 1988;65:487–492. [PMC free article] [PubMed] [Google Scholar]
  • 5.Musoke AJ, et al. The immunological response of the rat to infection with taeniaeformis. IV. Immunoglobulins involved in passive transfer of resistance from mother to offspring. Immunology. 1975;29:845–853. [PMC free article] [PubMed] [Google Scholar]
  • 6.Klementowicz JE, et al. Trichuris muris: a model of gastrointestinal parasite infection. Semin Immunopathol. 2012;34:815–828. doi: 10.1007/s00281-012-0348-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Hewitson JP, et al. Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity. Mol Biochem Parasitol. 2009;167:1–11. doi: 10.1016/j.molbiopara.2009.04.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Basten A, et al. Mechanism of eosinophilia. I. Factors affecting the eosinophil response of rats to Trichinella spiralis. J Exp Med. 1970;131:1271–1287. doi: 10.1084/jem.131.6.1271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Rosenberg HF, et al. Eosinophils: changing perspectives in health and disease. Nat Rev Immunol. 2013;13:9–22. doi: 10.1038/nri3341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Kopf M, et al. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity. 1996;4:15–24. doi: 10.1016/s1074-7613(00)80294-0. [DOI] [PubMed] [Google Scholar]
  • 11.Buys J, et al. The killing of newborn larvae of Trichinella spiralis by eosinophil peroxidase in vitro. Eur J Immunol. 1981;11:843–845. doi: 10.1002/eji.1830111018. [DOI] [PubMed] [Google Scholar]
  • 12.Capron M, et al. In vitro killing of S. mansoni schistosomula by eosinophils from infected rats: role of cytophilic antibodies. Journal of immunology. 1979;123:2220–2230. [PubMed] [Google Scholar]
  • 13.Spencer LA, Weller PF. Eosinophils and Th2 immunity: contemporary insights. Immunol Cell Biol. 2010;88:250–256. doi: 10.1038/icb.2009.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Ravin KA, Loy M. The Eosinophil in Infection. Clinical reviews in allergy & immunology. 2015 doi: 10.1007/s12016-015-8525-4. [DOI] [PubMed] [Google Scholar]
  • 15.Meeusen EN, Balic A. Do eosinophils have a role in the killing of helminth parasites? Parasitol Today. 2000;16:95–101. doi: 10.1016/s0169-4758(99)01607-5. [DOI] [PubMed] [Google Scholar]
  • 16.Behm CA, Ovington KS. The role of eosinophils in parasitic helminth infections: insights from genetically modified mice. Parasitol Today. 2000;16:202–209. doi: 10.1016/s0169-4758(99)01620-8. [DOI] [PubMed] [Google Scholar]
  • 17.Rothenberg ME, et al. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J Exp Med. 1997;185:785–790. doi: 10.1084/jem.185.4.785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Pope SM, et al. Identification of a cooperative mechanism involving interleukin-13 and eotaxin-2 in experimental allergic lung inflammation. J Biol Chem. 2005;280:13952–13961. doi: 10.1074/jbc.M406037200. [DOI] [PubMed] [Google Scholar]
  • 19.Pope SM, et al. The eotaxin chemokines and CCR3 are fundamental regulators of allergen-induced pulmonary eosinophilia. Journal of immunology. 2005;175:5341–5350. doi: 10.4049/jimmunol.175.8.5341. [DOI] [PubMed] [Google Scholar]
  • 20.Humbles AA, et al. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proceedings of the National Academy of Sciences of the United States of America. 2002;99:1479–1484. doi: 10.1073/pnas.261462598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Lee NA, et al. Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. Journal of immunology. 1997;158:1332–1344. [PubMed] [Google Scholar]
  • 22.Lee JJ, et al. Defining a link with asthma in mice congenitally deficient in eosinophils. Science. 2004;305:1773–1776. doi: 10.1126/science.1099472. [DOI] [PubMed] [Google Scholar]
  • 23.Yu C, et al. Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J Exp Med. 2002;195:1387–1395. doi: 10.1084/jem.20020656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Denzler KL, et al. Eosinophil major basic protein-1 does not contribute to allergen-induced airway pathologies in mouse models of asthma. Journal of immunology. 2000;165:5509–5517. doi: 10.4049/jimmunol.165.10.5509. [DOI] [PubMed] [Google Scholar]
  • 25.Denzler KL, et al. Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation. Journal of immunology. 2001;167:1672–1682. doi: 10.4049/jimmunol.167.3.1672. [DOI] [PubMed] [Google Scholar]
  • 26.Doyle AD, et al. Expression of the secondary granule proteins major basic protein 1 (MBP-1) and eosinophil peroxidase (EPX) is required for eosinophilopoiesis in mice. Blood. 2013;122:781–790. doi: 10.1182/blood-2013-01-473405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Jacobsen EA, et al. Eosinophils regulate dendritic cells and Th2 pulmonary immune responses following allergen provocation. Journal of immunology. 2011;187:6059–6068. doi: 10.4049/jimmunol.1102299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Padigel UM, et al. Eosinophils act as antigen-presenting cells to induce immunity to Strongyloides stercoralis in mice. J Infect Dis. 2007;196:1844–1851. doi: 10.1086/522968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Wen T, et al. Eosinophil adoptive transfer system to directly evaluate pulmonary eosinophil trafficking in vivo. Proceedings of the National Academy of Sciences of the United States of America. 2013;110:6067–6072. doi: 10.1073/pnas.1220572110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Jacobsen EA, et al. Eosinophil activities modulate the immune/inflammatory character of allergic respiratory responses in mice. Allergy. 2013 doi: 10.1111/all.12321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Matsuoka K, et al. Novel basophil- or eosinophil-depleted mouse models for functional analyses of allergic inflammation. PLoS One. 2013;8:e60958. doi: 10.1371/journal.pone.0060958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Shamri R, et al. Eosinophils in innate immunity: an evolving story. Cell Tissue Res. 2011;343:57–83. doi: 10.1007/s00441-010-1049-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Doyle AD, et al. Homologous recombination into the eosinophil peroxidase locus generates a strain of mice expressing Cre recombinase exclusively in eosinophils. J Leukoc Biol. 2013;94:17–24. doi: 10.1189/jlb.0213089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Nei Y, et al. GATA-1 regulates the generation and function of basophils. Proceedings of the National Academy of Sciences of the United States of America. 2013;110:18620–18625. doi: 10.1073/pnas.1311668110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Jacobsen EA, et al. Re-defining the Unique Roles for Eosinophils in Allergic Respiratory Inflammation. Clin Exp Allergy. 2014 doi: 10.1111/cea.12358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Taliaferro WH, Sarles MP. The Cellular Reactions in the Skin, Lungs and Intestine of Normal and Immune Rats after Infection with Nippostrongylus muris. J Infect Dis. 1939;64:157–192. [Google Scholar]
  • 37.Capron M, Capron A. Effector functions of eosinophils in schistosomiasis. Memorias do Instituto Oswaldo Cruz. 1992;87(Suppl 4):167–170. doi: 10.1590/s0074-02761992000800025. [DOI] [PubMed] [Google Scholar]
  • 38.Venturiello SM, et al. Immune cytotoxic activity of human eosinophils against Trichinella spiralis newborn larvae. Parasite Immunol. 1995;17:555–559. doi: 10.1111/j.1365-3024.1995.tb00998.x. [DOI] [PubMed] [Google Scholar]
  • 39.Bass DA, Szejda P. Eosinophils versus neutrophils in host defense. Killing of newborn larvae of Trichinella spiralis by human granulocytes in vitro. The Journal of clinical investigation. 1979;64:1415–1422. doi: 10.1172/JCI109599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Harris NL. Advances in helminth immunology: optimism for future vaccine design? Trends in parasitology. 2011;27:288–293. doi: 10.1016/j.pt.2011.03.010. [DOI] [PubMed] [Google Scholar]
  • 41.McCoy KD, et al. Polyclonal and specific antibodies mediate protective immunity against enteric helminth infection. Cell host & microbe. 2008;4:362–373. doi: 10.1016/j.chom.2008.08.014. [DOI] [PubMed] [Google Scholar]
  • 42.Liu Q, et al. B cells have distinct roles in host protection against different nematode parasites. Journal of immunology. 2010;184:5213–5223. doi: 10.4049/jimmunol.0902879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Knott ML, et al. Impaired resistance in early secondary Nippostrongylus brasiliensis infections in mice with defective eosinophilopoeisis. Int J Parasitol. 2007;37:1367–1378. doi: 10.1016/j.ijpara.2007.04.006. [DOI] [PubMed] [Google Scholar]
  • 44.Hewitson JP, et al. Concerted activity of IgG1 antibodies and IL-4/IL-25-dependent effector cells trap helminth larvae in the tissues following vaccination with defined secreted antigens, providing sterile immunity to challenge infection. PLoS pathogens. 2015;11:e1004676. doi: 10.1371/journal.ppat.1004676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Huang L, et al. Eosinophils mediate protective immunity against secondary nematode infection. Journal of immunology. 2015;194:283–290. doi: 10.4049/jimmunol.1402219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Esser-von Bieren J, et al. Antibodies trap tissue migrating helminth larvae and prevent tissue damage by driving IL-4Ralpha-independent alternative differentiation of macrophages. PLoS pathogens. 2013;9:e1003771. doi: 10.1371/journal.ppat.1003771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Obata-Ninomiya K, et al. The skin is an important bulwark of acquired immunity against intestinal helminths. J Exp Med. 2013;210:2583–2595. doi: 10.1084/jem.20130761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Munoz-Caro T, et al. Leucocyte-derived extracellular trap formation significantly contributes to Haemonchus contortus larval entrapment. Parasites & vectors. 2015;8:607. doi: 10.1186/s13071-015-1219-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Ueki S, et al. Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans. Blood. 2013;121:2074–2083. doi: 10.1182/blood-2012-05-432088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Ansari A, et al. Antibody-mediated secondary eosinophilic response to Taenia taeniaeformis in the rat. J Parasitol. 1976;62:737–740. [PubMed] [Google Scholar]
  • 51.Perrudet-Badoux A, et al. Trichinella spiralis infection in mice. Mechanism of the resistance in animals genetically selected for high and low antibody production. Immunology. 1978;35:519–522. [PMC free article] [PubMed] [Google Scholar]
  • 52.Blum LK, et al. Expulsion of secondary Trichinella spiralis infection in rats occurs independently of mucosal mast cell release of mast cell protease II. Journal of immunology. 2009;183:5816–5822. doi: 10.4049/jimmunol.0900944. [DOI] [PubMed] [Google Scholar]
  • 53.Tokoyoda K, et al. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity. 2004;20:707–718. doi: 10.1016/j.immuni.2004.05.001. [DOI] [PubMed] [Google Scholar]
  • 54.Winter O, et al. Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow. Blood. 2010;116:1867–1875. doi: 10.1182/blood-2009-12-259457. [DOI] [PubMed] [Google Scholar]
  • 55.Rozanski CH, et al. Sustained antibody responses depend on CD28 function in bone marrow-resident plasma cells. J Exp Med. 2011;208:1435–1446. doi: 10.1084/jem.20110040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Garcia De Vinuesa C, et al. Dendritic cells associated with plasmablast survival. Eur J Immunol. 1999;29:3712–3721. doi: 10.1002/(SICI)1521-4141(199911)29:11<3712::AID-IMMU3712>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
  • 57.Matthes T, et al. Production of the plasma-cell survival factor a proliferation-inducing ligand (APRIL) peaks in myeloid precursor cells from human bone marrow. Blood. 2011;118:1838–1844. doi: 10.1182/blood-2011-01-332940. [DOI] [PubMed] [Google Scholar]
  • 58.Rodriguez Gomez M, et al. Basophils support the survival of plasma cells in mice. Journal of immunology. 2010;185:7180–7185. doi: 10.4049/jimmunol.1002319. [DOI] [PubMed] [Google Scholar]
  • 59.Chu VT, et al. Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat Immunol. 2011;12:151–159. doi: 10.1038/ni.1981. [DOI] [PubMed] [Google Scholar]
  • 60.Chu VT, Berek C. Immunization induces activation of bone marrow eosinophils required for plasma cell survival. Eur J Immunol. 2012;42:130–137. doi: 10.1002/eji.201141953. [DOI] [PubMed] [Google Scholar]
  • 61.Wong TW, et al. Eosinophils regulate peripheral B cell numbers in both mice and humans. Journal of immunology. 2014;192:3548–3558. doi: 10.4049/jimmunol.1302241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.O'Connell AE, et al. Major basic protein from eosinophils and myeloperoxidase from neutrophils are required for protective immunity to Strongyloides stercoralis in mice. Infection and immunity. 2011;79:2770–2778. doi: 10.1128/IAI.00931-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Swartz JM, et al. Schistosoma mansoni infection in eosinophil lineage-ablated mice. Blood. 2006;108:2420–2427. doi: 10.1182/blood-2006-04-015933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Svensson M, et al. Accumulation of eosinophils in intestine-draining mesenteric lymph nodes occurs after Trichuris muris infection. Parasite Immunol. 2011;33:1–11. doi: 10.1111/j.1365-3024.2010.01246.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Fabre V, et al. Eosinophil deficiency compromises parasite survival in chronic nematode infection. Journal of immunology. 2009;182:1577–1583. doi: 10.4049/jimmunol.182.3.1577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Butterworth AE. Cell-mediated damage to helminths. Adv Parasitol. 1984;23:143–235. doi: 10.1016/s0065-308x(08)60287-0. [DOI] [PubMed] [Google Scholar]
  • 67.Hirashima M, et al. The mediation of tissue eosinophilia in hypersensitivity reactions. V. Comparative study of tissue eosinophilia in the skin lesions of local and systemic passive cutaneous anaphylactic reactions. Immunology. 1983;50:85–91. [PMC free article] [PubMed] [Google Scholar]
  • 68.Duez C, et al. Migration and accumulation of eosinophils toward regional lymph nodes after airway allergen challenge. J Allergy Clin Immunol. 2004;114:820–825. doi: 10.1016/j.jaci.2004.08.011. [DOI] [PubMed] [Google Scholar]
  • 69.Mawhorter SD, et al. Class II major histocompatibility complex molecule expression on murine eosinophils activated in vivo by Brugia malayi. Infection and immunity. 1993;61:5410–5412. doi: 10.1128/iai.61.12.5410-5412.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Cadman ET, et al. Eosinophils are important for protection, immunoregulation and pathology during infection with nematode microfilariae. PLoS pathogens. 2014;10:e1003988. doi: 10.1371/journal.ppat.1003988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Walsh ER, et al. Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma. J Exp Med. 2008;205:1285–1292. doi: 10.1084/jem.20071836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Jacobsen EA, et al. Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells. J Exp Med. 2008;205:699–710. doi: 10.1084/jem.20071840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Hokibara S, et al. Marked eosinophilia in interleukin-5 transgenic mice fails to prevent Trichinella spiralis infection. J Parasitol. 1997;83:1186–1189. [PubMed] [Google Scholar]
  • 74.Douglas DB, et al. Combinatorial effects of interleukin 10 and interleukin 4 determine the progression of hepatic inflammation following murine enteric parasitic infection. Hepatology. 2010;51:2162–2171. doi: 10.1002/hep.23576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Bliss SK, et al. IL-10 prevents liver necrosis during murine infection with Trichinella spiralis. Journal of immunology. 2003;171:3142–3147. doi: 10.4049/jimmunol.171.6.3142. [DOI] [PubMed] [Google Scholar]
  • 76.Gebreselassie NG, et al. Eosinophils preserve parasitic nematode larvae by regulating local immunity. Journal of immunology. 2012;188:417–425. doi: 10.4049/jimmunol.1101980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Beiting DP, et al. Coordinated control of immunity to muscle stage Trichinella spiralis by IL-10, regulatory T cells, and TGF-beta. Journal of immunology. 2007;178:1039–1047. doi: 10.4049/jimmunol.178.2.1039. [DOI] [PubMed] [Google Scholar]
  • 78.Helmby H, Grencis RK. Contrasting roles for IL-10 in protective immunity to different life cycle stages of intestinal nematode parasites. Eur J Immunol. 2003;33:2382–2390. doi: 10.1002/eji.200324082. [DOI] [PubMed] [Google Scholar]
  • 79.Huang L, et al. Eosinophil-derived IL-10 supports chronic nematode infection. Journal of immunology. 2014;193:4178–4187. doi: 10.4049/jimmunol.1400852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Lee MW, et al. Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell. 2015;160:74–87. doi: 10.1016/j.cell.2014.12.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Qiu Y, et al. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell. 2014;157:1292–1308. doi: 10.1016/j.cell.2014.03.066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Wu D, et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science. 2011;332:243–247. doi: 10.1126/science.1201475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Heredia JE, et al. Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell. 2013;153:376–388. doi: 10.1016/j.cell.2013.02.053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Goh YP, et al. Eosinophils secrete IL-4 to facilitate liver regeneration. Proceedings of the National Academy of Sciences of the United States of America. 2013;110:9914–9919. doi: 10.1073/pnas.1304046110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Sabin EA, et al. Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils. J Exp Med. 1996;184:1871–1878. doi: 10.1084/jem.184.5.1871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Voehringer D, et al. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity. 2004;20:267–277. doi: 10.1016/s1074-7613(04)00026-3. [DOI] [PubMed] [Google Scholar]
  • 87.Huang L, et al. Eosinophils and IL-4 Support Nematode Growth Coincident with an Innate Response to Tissue Injury. PLoS pathogens. 2015;11:e1005347. doi: 10.1371/journal.ppat.1005347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Molofsky AB, et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J Exp Med. 2013;210:535–549. doi: 10.1084/jem.20121964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Babayan SA, et al. Filarial parasites develop faster and reproduce earlier in response to host immune effectors that determine filarial life expectancy. PLoS Biol. 2010;8:e1000525. doi: 10.1371/journal.pbio.1000525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Voehringer D, et al. Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. J Exp Med. 2006;203:1435–1446. doi: 10.1084/jem.20052448. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES